| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/18/2003 | WO2003000864A8 Nucleic acid-associated proteins |
| 12/18/2003 | WO2003000723B1 Transport proteins for nitrogenous heterocycles and nucleic acids encoding them |
| 12/18/2003 | WO2002102852A3 Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeut ic use |
| 12/18/2003 | WO2002101065A3 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 12/18/2003 | WO2002101049A3 Interleukin-18 mutants, their production and use |
| 12/18/2003 | WO2002101012A9 Regulation of transgene expression following aav transduction |
| 12/18/2003 | WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein |
| 12/18/2003 | WO2002099095A3 Improved isoprenoid production |
| 12/18/2003 | WO2002099035A3 Chimeric alphavirus replicon particles |
| 12/18/2003 | WO2002095059A3 Selection of target sites for antisense attack of rna |
| 12/18/2003 | WO2002092613A3 Nucleic acid, which binds to gnrh |
| 12/18/2003 | WO2002090543A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein |
| 12/18/2003 | WO2002090509A3 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 12/18/2003 | WO2002090386A3 Regulatory protein involved in pectin modification |
| 12/18/2003 | WO2002086122A9 Protein-protein interactions in adipocytes |
| 12/18/2003 | WO2002086059A3 Recombinant vaccinia viral vectors |
| 12/18/2003 | WO2002085305A3 Compositions and methods for inducing cancer cell death |
| 12/18/2003 | WO2002082087A3 Diagnosis and treatment of enterococcus faecium related disease |
| 12/18/2003 | WO2002081668A3 Desaturase genes and uses thereof |
| 12/18/2003 | WO2002079474A3 Human b7 polypeptides |
| 12/18/2003 | WO2002079378A3 Transgenic mice containing gpcr-like transmembrane protein disruptions |
| 12/18/2003 | WO2002074977A3 Sugar and lipid metabolism regulators in plants |
| 12/18/2003 | WO2002074157A3 A mammalian immortalized liver cell |
| 12/18/2003 | WO2002072775A3 Lipid metabolism regulators in plants |
| 12/18/2003 | WO2002072773A3 Methods and compositions for amplification of rna sequences |
| 12/18/2003 | WO2002068621A3 Rax-related protein |
| 12/18/2003 | WO2002066504A3 Protein-protein interactions in saccharomyces cerevisiae |
| 12/18/2003 | WO2002062955A3 Dendritic enriched secreted lymphocyte activation molecule |
| 12/18/2003 | WO2002059378A3 Methods and compositions for identifying gene function |
| 12/18/2003 | WO2002059298A3 Gab2(p97) gene and methods of use thereof |
| 12/18/2003 | WO2002058724A3 Use of lp82 to treat body weight disorders |
| 12/18/2003 | WO2002058723A3 Chemokines as adjuvants of immune response |
| 12/18/2003 | WO2002057492A9 Methods and compositions for detecting polynucleotide duplex damage |
| 12/18/2003 | WO2002057423A3 Isolating cells expressing secreted proteins |
| 12/18/2003 | WO2002053778A3 Method for relative quantification of attached nucleic acids |
| 12/18/2003 | WO2002036759A3 Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases |
| 12/18/2003 | WO2002014536A9 Odulating multiple lineage kinase proteins |
| 12/18/2003 | WO2002007678A3 Mu-conopeptides |
| 12/18/2003 | WO2001034829A3 Nucleic acid sequence which encodes for an amino acid sequence capable of being cyclized within a cell or cell membrane |
| 12/18/2003 | WO2000065025A3 Dna molecules encoding human endothelin converting enzyme 3 |
| 12/18/2003 | WO2000040718A3 MUTANTS OF GNRPs AND VECTORS SUITABLE FOR THEIR EXPRESSION |
| 12/18/2003 | US20030233681 ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 12/18/2003 | US20030233680 Methods for modifying plant biomass and cell protectant levels |
| 12/18/2003 | US20030233679 Methods for controlling gibberellin levels |
| 12/18/2003 | US20030233678 Pre- and post-harvest inhibition of remobilisation of storage compounds |
| 12/18/2003 | US20030233677 Modification of fatty acid metabolism in plants |
| 12/18/2003 | US20030233676 Increasing host plant susceptibility to agrobacterium infection by overexpression of the arabidopsis VIP1 gene |
| 12/18/2003 | US20030233675 Expression of microbial proteins in plants for production of plants with improved properties |
| 12/18/2003 | US20030233674 Preparing and propagating transgenic tomatos comprising lycopersicon fungal resistant sequences; disease resistant plants; biological pest control |
| 12/18/2003 | US20030233672 Comprises zinc finger protein modulating which binds to gamma tocopherol methyltransferase (GMT) and modulates alpha-tocopherol content in plant organs |
| 12/18/2003 | US20030233671 Promoters for molecular farming and/or early detection of transgenic plants |
| 12/18/2003 | US20030233670 Gene sequences and uses thereof in plants |
| 12/18/2003 | US20030233669 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses |
| 12/18/2003 | US20030233218 Systems and methods for constructing genomic-based phenotypic models |
| 12/18/2003 | US20030232980 Methods of producing phosphitylated compounds |
| 12/18/2003 | US20030232979 Nucleic acid labeling compounds |
| 12/18/2003 | US20030232977 Antisense modulation of splicing factor R/S-rich 10 expression |
| 12/18/2003 | US20030232976 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections |
| 12/18/2003 | US20030232972 Rationally designed antibodies |
| 12/18/2003 | US20030232781 Modulation of gene expression using insulator binding proteins |
| 12/18/2003 | US20030232780 Composition comprising an immunomodulatory molecule, which molecule comprises an antigen conjugated to an polynucleotide that contains at least one immunostimulatory nucleotide sequence; for modulating an immune response in vertebrates |
| 12/18/2003 | US20030232778 Oligonucleotides, specifically hybridizable with nucleic acids encoding extracellular-signal-regulated kinase-6; can be used to modulate the expression of extracellular-signal-regulated kinase-6 |
| 12/18/2003 | US20030232777 An oligonucleotides or polynucleotides targeted to hybridization with the nucleic acids, gene expression inhibition, treating angiogenic diseases, metabolic disease, neurodegenerative disease, cancer, inflammation; gene therapy |
| 12/18/2003 | US20030232775 Antisense modulation of phosphatidylinositol-4-phosphate 5-kinase, type II beta expression |
| 12/18/2003 | US20030232774 Antisense modulation of profilin 1 expression |
| 12/18/2003 | US20030232773 An oligonucleotides or polynucleotides targeted to hybridization, death-associated protein kinase-inducing protein kinase 1, treating Alzheimer's disease, cancer, neurodegenerative disease, inflammation; gene therapy |
| 12/18/2003 | US20030232772 Antisense modulation of extracellular-signal-regulated kinase-6 expression |
| 12/18/2003 | US20030232771 Antisense modulation of MARK3 expression |
| 12/18/2003 | US20030232770 Antisense modulation of hypothetical tumor endothelial marker expression |
| 12/18/2003 | US20030232769 Antisense modulation of G protein-coupled receptor 39 expression |
| 12/18/2003 | US20030232768 Triple-helix forming oligonucleotides for targeted mutagenesis |
| 12/18/2003 | US20030232767 Activating cancerous cells response to therapeutic agents, by administering cisplatin or oxaliplatin, applying ionizing radiation and hydrogen peroxide |
| 12/18/2003 | US20030232764 Use of macrolides in pest control |
| 12/18/2003 | US20030232757 An insecticide protein is obtained from culturing Bacillus, nucleic acid sequence encoding an endotoxin polypeptide, a disease resistant plants |
| 12/18/2003 | US20030232755 Antitumor agents, anticarcinogenic agents, replacing another amino acid at 86, 87, and 88 of the amino acid sequence |
| 12/18/2003 | US20030232750 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2003 | US20030232443 Comprises oligonucleotides for controlling centromere protein B activities and expression; antisense therapy; gene expression inhibition; for treating cancer and autoimmune disorders |
| 12/18/2003 | US20030232442 Comprises oligonucleotides for controlling translation initiation protein (PAZ/PIWI); antisense therapy; gene expression inhibition; for treating cancer and aberrant cellular differentiation disorders |
| 12/18/2003 | US20030232441 Comprises oligonucleotides for controlling dual specificity phosphatase activities; antisense therapy; gene expression inhibition; for treating cancer, apoptotic and developmental disorder |
| 12/18/2003 | US20030232439 Antisense modulation of VEGF-B expression |
| 12/18/2003 | US20030232438 Antisense modulation of KOX 1 expression |
| 12/18/2003 | US20030232437 Antisense modulation of VEGF-C expression |
| 12/18/2003 | US20030232436 Comprises oligonucleotides for controlling endemic pemphigus foliaceus protein expression and activities; antisense therapy; gene expression inhibition; for treating skin and autoimmune disorders |
| 12/18/2003 | US20030232435 Antisense modulation of amyloid beta protein precursor expression |
| 12/18/2003 | US20030232434 Antisense modulation of PTPN12 expression |
| 12/18/2003 | US20030232430 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 12/18/2003 | US20030232421 Protein-protein interactions in adipocyte cells (3) |
| 12/18/2003 | US20030232420 Kinase anchor protein muteins, peptides thereof and related documents |
| 12/18/2003 | US20030232416 Synthesis of synthons for the manufacture of bioactive compounds |
| 12/18/2003 | US20030232415 Comprises nucleotide sequences coding protein associated with avermectin biosynthesis (AVEC); antibiotic preparation; veterinary medicine |
| 12/18/2003 | US20030232414 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 12/18/2003 | US20030232413 Transformed fungi for production of recombinant proteins |
| 12/18/2003 | US20030232410 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
| 12/18/2003 | US20030232406 Genetically engineered bacillus coding riboflavin biosynthetic protein (RIB) for fermention of vitamin b2 |
| 12/18/2003 | US20030232404 Comprises heat resistant beetle luciferase with increased half-life for use as diagnostic tool in genetic engineering |
| 12/18/2003 | US20030232402 Peptide nucleic acids for detecting bacteria in air, food, beverages, water, pharmaceutical, personal care, dairy, mail and/or packaging product |
| 12/18/2003 | US20030232395 Recombination of nucleic acid library members |
| 12/18/2003 | US20030232391 Identification of kinase inhibitors |
| 12/18/2003 | US20030232381 Fiber array and methods for using and making same |
| 12/18/2003 | US20030232376 Determining interference or disturbance in the co-modulation mechanism between androgen receptor proteins and the coactivator arginine methyltransferase (HSRNAAM) |